MAIN INDICATIONS
Thanks to its restructuring action of the perineurium, MD-NEURAL is a medical device designed to improve mobility and reduce neuropathic and muscular associated pain, counteracting physiological or pathological joint deterioration.
Scientific evidence shows the efficacy and safety of MD-NEURAL in cases of:
• Morton neuroma
• Neuralgia:
- due to prolonged bed rest
- due to aging
- due to bad posture
- due to concomitant chronic diseases
- due to traumas and injuries.
• Associated neuropathic pain due to various causes, such as:
- lumbar spine instability from degenerative spondylolisthesis
- herniated disc in the lumbar or lumbosacral vertebrae
- non-specific lumbago
- facial nerve palsy.
Treatment can be combined with other therapies.
THERAPEUTIC PROTOCOL:
1 treatment per week: injection in the trigger points and/or in the periarti-cular area of one (2 ml) or two vials (4 ml) per treatment. Results are evident from the third week but, depending on the patient's clinical situation, it is possible to continue treatment up to the tenth week without risk.
COMPOSITION
Collagen of porcine origin, Colocynthis, NaCI, Water for injection.
PACKAGE
Box of 10 vials (single vial 2 ml - extraction volume).
SUGGESTED NEEDLE
Periarticular: 26G x 13 mm needle; intramuscular: 26G x 13mm needle.
Note: Disinfect the skin thoroughly with iodopovidone or chlorhexidine.
INJECTION TECHNIQUES OF ADMINISTRATION
• Periarticular administration: insert the needle near the joint to a depth of 6-13 mm.
• Intramuscular administration: insert the needle into the trigger points at a depth of 5-8 mm.
